$CDXC 90 DAYS STOCK PRICE FORECAST

Stock Price

About the Company

ChromaDex Corp. is a science-based integrated nutraceutical company devoted to improving the way people age. ChromaDex scientists partner with leading universities and research institutions worldwide to discover, develop and create solutions to deliver the full potential of NAD and its impact on human health. Its flagship ingredient, NIAGEN® nicotinamide riboside, sold directly to consumers as TRU NIAGEN®, is backed with clinical and scientific research, as well as extensive IP protection. TRU NIAGEN® is helping the world AGE BETTER®.

CEO

Robert Fried

Exchange

NASDAQ

Website

www.chromadex.com

$62M

Total Revenue

110

Employees

$394M

Market Capitalization

-16.62

Price/Earning ratio

Similar Companies

Name Ticker Market Capitalization (USD M) Revenue (USD M) Price/Book Price/Earning Net Margin (%)
Conversion Labs Inc CVLB 108548 35213 3.74 42.66 7.33
Royalty Pharma plc RPRX 18925 2239 2.81 15.20 43.40
Organon & Co. OGN 8844 7891 -4.56 5.07 22.06
Arvinas Inc ARVN 3725 21 7.48 -22.56 -782.93
Tilray Inc TLRY 3241 564 1.08 -8.14 -66.49
ATAI Life Sciences N.V. ATAI 2272 20 4.78 -10.40 -932.88
Cronos Group Inc CRON 2097 57 1.32 -14.52 -258.59
Usana Health Sciences Inc USNA 2079 1254 4.73 14.98 11.09
NRX Pharmaceuticals Inc NRXP 1170 2321 0.45 5.05 9.91
Phathom Pharmaceuticals Inc PHAT 1033 7.01 -6.45 None
Intersect ENT Inc XENT 893 103 21.65 -13.01 -66.55
Phibro Animal Health Corp. PAHC 893 833 3.70 16.25 6.53
Edgewise Therapeutics Inc EWTX 796 2.70 -29.55 None
Fulcrum Therapeutics Inc FULC 711 15 8.62 -9.63 -481.07
Pliant Therapeutics Inc PLRX 614 13 2.51 -7.16 -613.56
Cyteir Therapeutics Inc CYT 596 3.20 -20.62 None
Urovant Sciences Ltd UROV 503 -3.65 -3.08 None
Ikena Oncology Inc IKNA 404 10 2.18 -7.38 -551.28
Chromadex Corp CDXC 394 62 9.92 -16.62 -37.51
Provention Bio Inc PRVB 377 2.53 -2.94 None
Rain Therapeutics Inc RAIN 355 413 2.19 -11.66 123.20
Verrica Pharmaceuticals Inc VRCA 325 12 6.57 -8.92 -301.45
Evolus Inc EOLS 310 77 4.10 -2.08 -171.53
Terns Pharmaceuticals Inc TERN 252 1.40 -7.30 None
Adicet Bio Inc ACET 251 9 1.09 -4.46 -603.06
Milestone Pharmaceuticals Inc MIST 219 15 1.23 -7.37 -215.93
Kaleido Biosciences Inc KLDO 184 1 4.11 -2.07 None
Citius Pharmaceuticals Inc CTXR 179 2.24 -7.81 None
scPharmaceuticals Inc SCPH 167 119 2.45 -5.52 -27.05
Eyenovia Inc EYEN 143 6 16.29 -7.31 -324.94
Aquestive Therapeutics Inc AQST 142 42 -2.95 -2.21 -152.73
LifeMD Inc LFMD 139 64 -22.39 -1.00 -133.55
Eton Pharmaceuticals Inc ETON 124 15 6.13 -10.10 -74.52
Osmotica Pharmaceuticals Plc OSMT 122 190 2.37 -1.31 -47.85
Kala Pharmaceuticals Inc KALA 119 11 1.53 -0.94 None
Xeris Biopharma Holdings Inc XERS 111 34 12.19 -1.44 -248.46
Odonate Therapeutics Inc ODT 110 1.39 -0.94 None
Anebulo Pharmaceuticals Inc ANEB 102 7.93 -2.58 None
Opiant Pharmaceuticals Inc OPNT 100 37 3.03 -96.15 -3.06
Aerpio Pharmaceuticals Inc ARPO 99 15 2.98 -5.24 -28.77
Mannatech Inc MTEX 82 158 3.27 12.89 4.22
Natural Alternatives Internati NAII 80 179 1.07 7.90 6.03
India Globalization Capital In IGC 67 0 2.45 -7.60 -981.18
VYNE Therapeutics Inc VYNE 51 16 0.77 2.31 -554.66
Shineco Inc TYHT 44 3 2.17 -1.55 -159.60
Assertio Holdings Inc ASRT 36 117 0.49 -0.63 -38.05
Dermata Therapeutics Inc DRMA 36 -75.67 -7.32 None
Acasti Pharma Inc ACST 33 0 1.43 -1.66 -611.47
Nabriva Therapeutics Plc NBRV 29 12 0.88 -0.49 -452.55
Lexaria Bioscience Corp LEXX 27 1 3.76 -6.95 -445.15
Bio-Path Holdings Inc BPTH 26 0 1.19 -2.49 18.96
Reviva Pharmaceuticals Holding RVPH 25 1.41 -4.08 None
Baudax Bio Inc BXRX 25 1 -10.80 0.76 9.10
Trevi Therapeutics Inc TRVI 23 1.64 -0.66 None
Timber Pharmaceuticals Inc TMBR 20 0 8.75 0.67 -527.55
Hoth Therapeutics Inc HOTH 19 1.64 -2.02 None
Cyanotech Corp. CYAN 17 34 0.99 13.57 3.83
Sonoma Pharmaceuticals Inc. SNOA 11 17 3.32 -2.16 -31.96

Riding the Trend or Protecting Profits | ChromaDex Corporation (CDXC)

20h ago, source: newsheater

ChromaDex Corporation (NASDAQ:CDXC) went down by -7.86% from its latest closing price compared to the recent 1-year high of $23.66. The company’s stock price has collected -9.98% of loss in the last ...

ChromaDex Corporation (NASDAQ: CDXC) Shocks Wall Street This Week With A -7.86% Stock Price Decline

18h ago, source: marketingsentinel

ChromaDex Corporation (NASDAQ:CDXC) has a beta value of 1.72 and has seen 1.1 million shares traded in the last trading ...

Why is ChromaDex Corporation (CDXC) up 17.20% from the day 1 this year?

16h ago, source: investchronicle

For the readers interested in the stock health of ChromaDex Corporation (CDXC). It is currently valued at $5.86. When the transactions were called off in the previous session, Stock hit the highs of ...

ChromaDex Shares Findings from First Clinical Study on Nicotinamide Riboside (NR) in Children, Highlighting Improvements for Prematurely Aging Patients with Ataxia ...

1d ago, source: Business Wire

ChromaDex Corp. (NASDAQ:CDXC) today announced promising findings from a first-of-its-kind clinical study published in the peer-reviewed journal, Movem ...

Buying ChromaDex Corporation (NASDAQ: CDXC)? Here Are Some Things To Consider

3d ago, source: stocksregister

ChromaDex Corporation (NASDAQ:CDXC) shares, rose in value on Friday, 10/15/21, with the stock price down by -5.07% to the previous day’s close as strong demand from buyers drove the stock to $6.36.

ChromaDex Comments on Jury Award Against Elysium Health and Reiterates Plans for Growth

18d ago, source: Yahoo Finance

About ChromaDex: ChromaDex Corp. is a global bioscience company dedicated to healthy aging. The ChromaDex team, which includes world-renowned scientists, is pioneering research on nicotinamide ...

DarioHealth Unveils its Digital Musculoskeletal Solution Dario Move at HLTH 2021

1d ago, source: Le Lézard

DarioHealth Corp. , a leader in the global digital therapeutics (DTx) market, announced today the launch of Dario Move, a new digital physical therapy solution to manage common musculoskeletal (MSK) ...

Hoi Shuen Chau of ChromaDex Corporation (NASDAQ:CDXC) Just Spent US$2.2m On Shares

26d ago, source: Nasdaq

Those following along with ChromaDex Corporation (NASDAQ:CDXC) will no doubt be intrigued by the recent purchase of shares by insider Hoi Shuen Chau, who spent a stonking US$2.2m on stock at an ...

ChromaDex Partners with Sinopharm Xingsha for Cross-Border Sales of Tru Niagen® into Mainland China

20d ago, source: Stockhouse

ChromaDex Corp. (NASDAQ: CDXC) announced today a partnership with Sinopharm Xingsha Pharmaceuticals (Xiamen) Co., Ltd. (“Sinopharm Xingsha”) to conduct cross-border sales of Tru ...

ChromaDex Comments on Jury Award Against Elysium Health and Reiterates Plans for Growth

18d ago, source: The Register-Herald

ChromaDex Corp. (NASDAQ:CDXC) today announced that a jury in the United States District Court for the Central District of California found that Elysium Health, Inc. (“Elysium”) breached its ...

Your Portfolio